Employees: 03 (2023.0)Legal category: 5785Size: PMECreation date: 1998-05-01 (28 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: ANSE (69480), Rhone
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SELAS PHARMACIE DES PIERRES DOREES : revenue, balance sheet and financial ratios
SELAS PHARMACIE DES PIERRES DOREES is a French company
founded 28 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in ANSE (69480),
this company of category PME
shows in 2019 a revenue of 2.3 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELAS PHARMACIE DES PIERRES DOREES (SIREN 418824470)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
2 271 396 €
N/C
N/C
N/C
Net income
81 808 €
92 400 €
140 802 €
177 683 €
90 805 €
125 913 €
99 457 €
40 075 €
47 722 €
-16 647 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
161 440 €
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
4.4%
N/C
N/C
N/C
Revenue and income statement
In 2025, SELAS PHARMACIE DES PIERRES DOREES generates positive net income of 82 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
81 808 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 81%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 42%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
81.493%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
41.585%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution SELAS PHARMACIE DES PIERRES DOREES
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
9146.745
2070.099
1163.113
548.254
336.434
230.453
164.489
123.046
99.848
81.493
Financial autonomy
0.807
3.405
5.633
11.137
18.026
24.903
30.314
34.377
36.972
41.585
Repayment capacity
None
None
None
22.597
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
2.164%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
81.492025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Average
In 2025, the debt ratio of SELAS PHARMACIE DES PIERR... (81.49) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
41.59%2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Average
In 2025, the financial autonomy of SELAS PHARMACIE DES PIERR... (41.6%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 82.69. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
82.694
Liquidity indicators evolution SELAS PHARMACIE DES PIERRES DOREES
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
71.114
62.178
53.739
58.264
74.966
102.34
89.63
99.268
98.208
82.694
Interest coverage
None
None
None
25.953
None
None
None
None
None
None
Sector positioning
Liquidity ratio
82.692025
2023
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Watch
In 2025, the liquidity ratio of SELAS PHARMACIE DES PIERR... (82.69) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution SELAS PHARMACIE DES PIERRES DOREES
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Operating WCR
0 €
0 €
0 €
-25 440 €
0 €
0 €
0 €
0 €
0 €
0 €
Inventory turnover (days)
0
0
0
29
0
0
0
0
0
0
Customer payment term (days)
0
0
0
7
0
0
0
0
0
0
Supplier payment term (days)
0
0
0
44
0
0
0
0
0
0
Positioning of SELAS PHARMACIE DES PIERRES DOREES in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of SELAS PHARMACIE DES PIERRES DOREES is estimated at
1 299 529 €
(range 881 867€ - 2 039 141€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
881k€1299k€2039k€
1 299 529 €Range: 881 867€ - 2 039 141€
NAF 5 année 2025
Valuation method used
Net Income Multiple
81 808 €
×
15.9x
=1 299 530 €
Range: 881 867€ - 2 039 141€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELAS PHARMACIE DES PIERRES DOREES with other companies in the same sector:
Frequently asked questions about SELAS PHARMACIE DES PIERRES DOREES
What is the revenue of SELAS PHARMACIE DES PIERRES DOREES ?
The revenue of SELAS PHARMACIE DES PIERRES DOREES in 2019 is 2.3 M€.
Is SELAS PHARMACIE DES PIERRES DOREES profitable?
Yes, SELAS PHARMACIE DES PIERRES DOREES generated a net profit of 82 k€ in 2025.
Where is the headquarters of SELAS PHARMACIE DES PIERRES DOREES ?
The headquarters of SELAS PHARMACIE DES PIERRES DOREES is located in ANSE (69480), in the department Rhone.
Where to find the tax return of SELAS PHARMACIE DES PIERRES DOREES ?
The tax return of SELAS PHARMACIE DES PIERRES DOREES is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELAS PHARMACIE DES PIERRES DOREES operate?
SELAS PHARMACIE DES PIERRES DOREES operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart